Investigator
Shaomeng Wang
UNIVERSITY OF MICHIGAN AT ANN ARBOR · funded by NCI
- Companies
- 1
- Grants
- 3
- Non-dilutive funding
- $2.0M
- First award
- Sep 1, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Mar 1, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Medsyn Biopharma LLC55momentum
OncologyFormed
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Orally active CBP/p300 degraders
$673kMar 1, 2024NCIUNIVERSITY OF MICHIGAN AT ANN ARBORNIH RePORTER · 11046643 (opens the source filing in a new tab)
- R01
Orally active CBP/p300 degraders
$656kMar 1, 2024NCIUNIVERSITY OF MICHIGAN AT ANN ARBORNIH RePORTER · 11294285 (opens the source filing in a new tab)
- R01
Small-molecule degraders of STAT5
$647kSep 1, 2023NCIUNIVERSITY OF MICHIGAN AT ANN ARBORNIH RePORTER · 11162336 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources